Healthcare >> CEO Interviews >> September 30, 1999
CRAIG R. SMITH, M.D., co-founded Guilford Pharmaceuticals, Inc. in July
and began his service to the company as a Director. He was elected
President and CEO in August 1993 and was appointed Chairman of the Board
in January 1994. Prior to joining the company, Dr. Smith was Senior Vice
President for Business and Market Development at Centocor, Inc., a
biotechnology company, where he participated in the establishment of
business and negotiating strategies for the company. Dr. Smith joined
Centocor in 1988 as Vice President of Clinical Research beginning his
career in the pharmaceutical industry after serving on the Faculty of
the Department of Medicine at Johns Hopkins Medical School for 13 years.
During his term at Johns Hopkins, Dr. Smith founded and directed the
Division of Internal Medicine and the Johns Hopkins Pharmacoepidemiology
Program. He received his B.A. degree in Biology from the University of
the South in 1968, his M.D. from the State University of New York at
Buffalo in 1972, and completed his Internship and Residency in Internal
Medicine at The Johns Hopkins Hospital in 1975. In July 1997, Dr. Smith
was named Maryland's Entrepreneur of the Year in the Technology
division. Dr. Smith serves on the Boards of the Maryland Chapter of the
Cystic Fibrosis Foundation, MD-Bio, a nonprofit quasi-public corporation
supporting early stage biotechnology companies in Maryland, and the
Greater Baltimore High Tech Council. Profile
Pharmaceuticals?
Dr. Smith: Guilford was incorporated in July of 1993. Since that time,
we've been engaged in building a
